Academic literature on the topic 'Inhaled corticosteriods'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Inhaled corticosteriods.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Inhaled corticosteriods"
SHI, Yali, and Wenjing ZHANG. "Medication analysis and treatment of a case of celostomia caused by inhaled corticosteriods." Pharmaceutical Care and Research 21, no. 1 (February 28, 2021): 66–68. http://dx.doi.org/10.5428/pcar20210115.
Full textFISH, JAMES E, STEPHEN P PETERS, CHRISTOPHER V CHAMBERS, STEPHEN J McGEADY, KENNETH R EPSTEIN, HOMER A BOUSHEY, REUBEN M CHERNIACK, et al. "An Evaluation of Colchicine as an Alternative to Inhaled Corticosteriods in Moderate Asthma." American Journal of Respiratory and Critical Care Medicine 156, no. 4 (October 1997): 1165–71. http://dx.doi.org/10.1164/ajrccm.156.4.9703012.
Full textSelf, Timothy, Mark J. Rumbak, Tiffany Kelso, Louis Eberle, Nabil Abou-Shala, Cheryl C. Learned, Nicole Beiers, and Elizabeth Tolley. "Does salmeterol facilitate “step-down” therapy in patients with asthma receiving moderate to high doses of inhaled corticosteriods?" Current Therapeutic Research 59, no. 11 (November 1998): 803–11. http://dx.doi.org/10.1016/s0011-393x(98)85106-0.
Full textTHARWANI, ARSAL, HIMANSHU DESHWAL, and JOSEPH PARAMBIL. "USE OF INHALED CORTICOSTERIODS/LONG-ACTING BETA AGONIST (ICS-LABA) IN PATIENTS WITH BRONCHIOLITIS CAUSED BY SJÖGREN SYNDROME DECREASES NEED FOR ORAL STEROIDS." Chest 162, no. 4 (October 2022): A2193. http://dx.doi.org/10.1016/j.chest.2022.08.1812.
Full textWu, Ann Chen, Pamela M. McMahon, Emily Welch, Cheryl N. McMahill-Walraven, Aziza Jamal-Allial, Mia Gallagher, Tancy Zhang, et al. "Characteristics of new adult users of mepolizumab with asthma in the USA." BMJ Open Respiratory Research 8, no. 1 (November 2021): e001003. http://dx.doi.org/10.1136/bmjresp-2021-001003.
Full textPizzichini, Marcia MM, Emilio Pizzichini, Krishnan Parameswaran, Lynda Clelland, Ann Efthimiadis, Jerry Dolovich, and Frederick E. Hargreave. "Nonasthmatic Chronic Cough: No Effect of Treatment with an Inhaled Corticosteriod in Patients without Sputum Eosinophilia." Canadian Respiratory Journal 6, no. 4 (1999): 323–30. http://dx.doi.org/10.1155/1999/434901.
Full textReardon, G., and P. Navaratnam. "Risk Factors for Exacerbations in Pediatric Asthmatic Patients Receiving Montelukast Monotherapy (MON) Who Step Up to an Inhaled Corticosteriod (ICS) or a Fixed-Dose Combination of ICS and Long-Acting Beta Agonist (ICSLABA)." Journal of Allergy and Clinical Immunology 125, no. 2 (February 2010): AB171. http://dx.doi.org/10.1016/j.jaci.2009.12.668.
Full text"META-ANALYSIS OF INHALED CORTICOSTERIODS AND SHORT TERM GROWTH IN ASTHMATIC CHILDREN." Paediatric Respiratory Reviews 7 (January 2006): S264. http://dx.doi.org/10.1016/j.prrv.2006.05.006.
Full textDissertations / Theses on the topic "Inhaled corticosteriods"
Sothirajah, Shobana. "Clinical Algorithms for Maintaining Asthma Control." Thesis, The University of Sydney, 2008. http://hdl.handle.net/2123/3546.
Full textSothirajah, Shobana. "Clinical Algorithms for Maintaining Asthma Control." University of Sydney, 2008. http://hdl.handle.net/2123/3546.
Full textRationale: Asthma management aims to achieve optimal control on the minimal effective dose of medication. We assessed the effectiveness of two algorithms to guide ICS dose in well-controlled patients on ICS+LABA in a double-blind study, comparing dose adjustment guided by exhaled nitric oxide (eNO) to clinical care algorithm(CCA) based on symptoms and lung function. Methods: We randomised non-smoking adult asthmatics on minimum FP dose 100μgs daily +LABA to ICS adjustment using eNO or CCA, assessed over 5 visits during 8 months treatment. Primary endpoints were asthma-free days and asthma related quality of life (QOL). Analysis was by mixed model regression and generalised estimating equations with log link. Results: 69 subjects were randomised (eNO:34, CCA:35) and 58 completed the study. At baseline mean FEV1 was 94% pred., mean eNO (200ml/sec) 7.1 ppb, median ACQ6 score 0.33. Median ICS dose was 500 μg (IQR 100-500) at baseline and 100 μg on both eNO (IQR 100-200) and CCA arms (IQR 100–100) at end of study. There were no significant differences between eNO and CCA groups in asthma-free days (RR=0.92, 95% CI 0.8–1.01), AQL (RRAQL
Conference papers on the topic "Inhaled corticosteriods"
Land, Cassia L., Jennifer Walker, Kevin Frick, Mona Tsoukleris, and Arlene Butz. "Association Of Pharmacy Location With Fills Of Inhaled Corticosteriods (ICS) In Urban Children With Asthma." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3808.
Full text